The small cell lung cancer (SCLC) drug market is predicted to double by 2017, despite “disappointing” drug development in this area

2009 ◽  
Vol 576 (1) ◽  
pp. 15-15
Keyword(s):  
Lung Cancer ◽  
Drug Development ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Drug Market ◽  
Small Cell ◽  
Small Cell Lung

scholarly journals Circulating tumor cell eXplants (CDX) to advance small cell lung cancer (SCLC) research and drug development

2016 ◽  
Vol 11 (2) ◽  
pp. S3
Author(s):  
Caroline Dive ◽  
Kris Frese ◽  
Ged Brady ◽  
Jonathan Tugwood ◽  
Crispin Miller ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Drug Development ◽  
Tumor Cell ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Circulating Tumor Cell ◽  
Small Cell ◽  
Small Cell Lung

ALK translocation and crizotinib in non-small cell lung cancer: An evolving paradigm in oncology drug development

2012 ◽  
Vol 48 (7) ◽  
pp. 961-973 ◽  
Author(s):  
Giorgio Scagliotti ◽  
Rolf A. Stahel ◽  
Rafael Rosell ◽  
Nick Thatcher ◽  
Jean-Charles Soria
Keyword(s):  
Lung Cancer ◽  
Drug Development ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Oncology Drug ◽  
Oncology Drug Development

The non-small-cell lung cancer drug market

2016 ◽  
Vol 15 (4) ◽  
pp. 229-230 ◽  
Author(s):  
Khurram Nawaz ◽  
Rachel M. Webster
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Drug Market ◽  
Small Cell ◽  
Cancer Drug ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document